Psychedelics field looks ahead after FDA advisers' rejection.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 38870296.
- Also identified by DOI 10.1126/science.adr0286.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Reeling from negative vote on MDMA-assisted PTSD therapy, researchers seek lessons for future studies.